Entheon Biomedical to acquire Lobo Genetics

  • Entheon Biomedical (OTCQB:ENTBF +2.8%) has entered into a definitive agreement to acquire personalized genetics company Lobo Genetics.
  • Pursuant to the agreement, the company will issue an aggregate of 5M shares to the shareholders of Lobo.
  • Under the deal, which is structured as a

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.